Ibum Sprint (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins. Lower prostaglandin levels decrease inflammation, diminish pain signals, and help reset the body’s temperature regulation center.

The appropriate dose of Ibum Sprint is determined by a qualified prescriber based on the patient’s age, weight, medical condition, and treatment goals. Patients should follow the healthcare professional’s instructions and not exceed the recommended amount.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester and used only when clearly needed in earlier stages. Breastfeeding mothers should consult a healthcare provider before use.

To order Ibum Sprint, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibum Sprint’s active ingredient, ibuprofen, offers a balance of analgesic, antipyretic, and anti‑inflammatory effects with a relatively favorable gastrointestinal safety profile compared with some older NSAIDs. However, individual response and risk factors vary, so clinicians choose the most appropriate NSAID based on patient history and therapeutic goals.

Ibum Sprint should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and excessive heat to maintain its stability and potency throughout its shelf life.

Ibum Sprint is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help reduce the likelihood of stomach upset. The exact administration schedule is set by the prescribing clinician.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, and renal impairment, especially with prolonged use or in patients with existing kidney disease. Patients should seek immediate medical attention if they experience symptoms like black stools, severe abdominal pain, swelling, or difficulty breathing.

Ibum Sprint should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers, severe renal or hepatic impairment, and pregnant women in the third trimester. Patients with cardiovascular disease or on anticoagulant therapy should consult a healthcare professional before use.